TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Target-lesion failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Repair of corneal epithelium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circ0014614 copies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vitamin D response index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the Deliberate Self-Harm Inventory (DSHI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intravaginal ejaculation latency time (ILET)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score of Arabic index of premature ejaculation (AIPE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Manual muscle testing results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endoscopists' accuracy of tip control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of radical (R0) resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: number of possible diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: correct diagnosis reached
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tendency toward disclosure by patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of incontinence-associated dermatitis (IAD)
Endpoint domain: Adverse events/effects
Primary endpoint: change in serum IgG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change of Metabolism and Metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Motivation and Pleasure Scale (MAP)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in stress myocardial blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perioperative allogeneic red blood cell transfusion volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in effective connectivity of Brain data
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Quantification equivalence of images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intrahepatic progression-free survival (iPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients with an Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with an adverse drug reaction (ADR)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with a serious AE (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of laparoscopic cholecystectomy
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of treatment adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients screened
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of patients screened who meet inclusion/exclusion criteria
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Enrollment percentage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pressure ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Poor oral health
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of TNF-a and IL-17A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of patients reaching EtO2 of 90%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of cash transfers
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SRS-22 patient questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Safety of pulse-dosed ceftriaxone
Endpoint domain: Adverse events/effects
Primary endpoint: Tolerability of pulse-dosed ceftriaxone
Endpoint domain: Adverse events/effects
Primary endpoint: Impact of back pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 10-day Longitudinal Antimicrobial Spectrum Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Participants Experiencing Escalation in Treatment
Endpoint domain: Adverse events/effects
Primary endpoint: miRNA expression profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Periprocedural major adverse event (MAE) rate
Endpoint domain: Adverse events/effects
Primary endpoint: Chronic post-Chikungunya rheumatological phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Association between primary headaches and irritable bowel syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: High-definition electromyography (HD-EMG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Intra-operative pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective Overall Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Acceptability of implementation strategies
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of implementation strategies
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cardiac magnetic resonance imaging changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diagnosis of sarcopenia (muscle strength)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in adrenocorticotropic hormone (ACTH) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in pain stress
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Labor Agentry Scale-10 (LAS-10)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Affect-Adjective Scale (modified) (AAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient-Reported Outcomes Measurement Information System Global Health (PROMIS G10)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Conditioned pain modulation (CPM) response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma levels of circulating dd-cfDNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: opioid requirement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change of cytokine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change of metabolite levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in neuropsychiatric scales for Insomnia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Thickness of the Transverse Abdominal Muscle (TrA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of peritoneal carcinomatosis
Endpoint domain: Mortality/survival
Primary endpoint: Mean difference in monocular Best Corrected Distance Visual Acuity (BCDVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in monocular Distance Corrected Intermediate Visual Acuity (DCIVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in monocular Distance Corrected Near Visual Acuity (DCNVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Marginal bone loss in mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Criminal recidivism
Endpoint domain: Mortality/survival
Primary endpoint: Panic Disorder Severity Scale (PDSS-SR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: survival time of CAR-T
Endpoint domain: Mortality/survival
Primary endpoint: antitumor effects after reinfusion of CAR-T
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Urgent visit resulting in intravenous therapy for HF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hospital readmission for acute or worsened HF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Insulin sensitivity index for glucose disposal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in psychotic factor score at T1
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in psychotic factor score at T2
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Target Area Hair Counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reticulocyte hemoglobin equivalent (Ret-He, pg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: reticulocyte count (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Work productivity impairment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Response Time During Go/No-Go (GNG) Task for Participants in Aim 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of Errors During Go/No-Go (GNG) Task for Participants in Aim 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stopping Time During Modified Stop Signal (MSS) Task for Participants in Aim 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prenatal hepatitis B surface markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Newborn condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper limb functionality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-PCI Acute Myocardial Reperfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rates of Completion of a Visually Verified Advance Directive
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in office diastolic blood pressure (DBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Type and frequency of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Acne lesion and residual marks count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: repeated hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: death through day 30
Endpoint domain: Mortality/survival
Primary endpoint: Renal-replacement therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Generation of adult AML PDX models
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of true positive results of FNAC after thyroidectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of malignant thyroid nodules not observed by FNAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of false negative results by FNAC
Endpoint domain: Adverse events/effects
Primary endpoint: Systolic and diastolic function alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: self reported mind wandering
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Frequency of cranioplasty revisions
Endpoint domain: Adverse events/effects
Primary endpoint: CHALNA2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline knowledge about human rights of persons with psychosocial disabilities post-training
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline attitudes towards persons with psychosocial disabilities role as rights-holders post-training
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Occurrence of decreased TIMI flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HIV prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percent of patients demonstrating simultaneous Rad51 activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of modified melasma area severity index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change of lightness value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Patient overall survival
Endpoint domain: Mortality/survival
Primary endpoint: Intervention Usability Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: User Burden Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Client Satisfaction Questionnaire - 8
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mediterranean Diet Adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of symptoms of maternity blues
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: accuracy with AI-assisted diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: % Acid Exposure Time (%AET)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Activity Scale for Individuals with Physical Disabilities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cmax of SNC-109 Cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax of SNC-109 Cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of SNC-109 Cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of SNC-109 CAR vector copy number
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax of SNC-109 CAR vector copy number
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression levels of proteins and metabolites in the perilymph
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression levels of proteins and metabolites in the blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Numerical Pain Rating Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk position sense
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived System Feasibility of the CAST Program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Difference of Perceived Ease of Use of the CAST Program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Difference of Perceived System Usefulness of the CAST Program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of ALXN2050
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Reach Cmax (Tmax) of ALXN2050
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration Versus Time Curve From Time 0 to the Time of Last Measurable Concentration (AUC0-last) of ALXN2050
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Body Composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: UDCA response according to Paris I criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UDCA response according to Barcelona criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Suicidal Ideation Questionnaire Junior (SIQ-JR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Center for Epidemiological Studies-Depression Scale (CES-D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Suicide Attempt Self-Injury Interview
Endpoint domain: Adverse events/effects
Primary endpoint: Change in pain disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Preoperative nutritional status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: rate of intraoperative diagnosis of placenta accreta spectrum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: calculated amount of blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: blood transfusion
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Ki-67 positive cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-abdominal Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of night awakenings
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Brain molecular pathology measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: laryngeal sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Accuracy of Implant Placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Stability of Implant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Prevalence of liver steatosis and MASLD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of liver fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of at-risk MASH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip flexors range of movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Count of patients with a flu vaccination
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement degree of ulcerative colitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Frequency of HPV16-specific T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Bleeding complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Requirements for transfusions and other blood products
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of polyethylene wear particles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Equivalent circle diameter of polyethylene wear particles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aspect ratio of polyethylene wear particles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Roundness of polyethylene wear particles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived stability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Activity Restriction
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Echocardiography results detecting HFpEF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Abdominal ultrasound results detecting NAFLD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Net change in muscle protein synthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Success rates of ECV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of oxyhemoglobin concentration during upper limb tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change of desoxyhemoglobin concentration during upper limb tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of patients with adequate visualization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional brain activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in pro-inflammatory markers concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in inflammation marker level: high sensitivity CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cross sectional area of quadriceps muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes